Document:

Form of Stock Option Agreement

 Exhibit 10.12 
 A.D.A.M., INC. 
 STOCK OPTION GRANT 
 A.D.A.M., Inc., a Georgia corporation (the “Company”), hereby grants to the optionee named below (“Optionee”) an option (this
“Option”) to purchase the total number of shares shown below of Common Stock of the Company (the “Shares”) at the exercise price per share set forth below (the “Exercise Price”), subject to all of the terms and
conditions on the reverse side of this Stock Option Grant (“Grant”) and the Company’s 2002 Stock Incentive Plan, as amended to the date hereof (the “Plan”). If designated as an Incentive Stock Option below, this Option is
intended to qualify as an “incentive stock option” (“ISO”) within the meaning of Section 422 of the Internal Revenue Code of 1986, as amended (the “Code”). Unless otherwise defined herein, capitalized terms used
herein shall have the meanings ascribed to them in the Plan. The terms and conditions set forth on the reverse side hereof and the terms and conditions of the Plan are incorporated herein by reference. 
 In witness whereof, this Stock Option Grant has been executed by the Company by a duly authorized officer as of the date specified hereon. 
 A.D.A.M., INC. 
 By:                                       
                                         
                 
 Title: Chief Financial
Officer                                        
 
 Date of
Grant:                                        
                                    
 Shares Subject to Option:
                                         
            
 Exercise Price Per Share:
$                                         
           
 Term of Option:  10 Years from Date of
Grant             
 Certificate
Number:                                        
                         
 Type
of Stock Option: 
               X      Incentive

                       Nonqualified

 Optionee hereby acknowledges receipt of a copy of the Plan, represents that Optionee has read and understands the terms and provisions of
the Plan, and accepts this Option subject to all the terms and conditions of the Plan and this Stock Option Grant. Optionee acknowledges that there may be adverse tax consequences upon exercise of this Option or disposition of the Shares and that
Optionee should consult a tax adviser prior to such exercise or disposition. The Optionee must sign and return this grant within fifteen (15) business days; if not, the grant is considered null and void. 
  

	
	  

	Signature of Optionee
	
	  

	Name and SSN of Optionee

 1. Exercise Period of Option. Subject to the terms and conditions of this
Grant and the Plan and unless otherwise modified by a written modification signed by the Company and Optionee, this Option may be exercised with respect to all of the shares of Common Stock covered by this Option (“Option Shares”) prior to
the date which is the last day of the Term set forth on the face hereof following the Date of Grant (hereinafter “Expiration Date”) as follows: (a) after one (1) year of continuous employment following the Date of Grant, Optionee
shall be entitled to exercise the Option as to thirty-three percent (33%) of the Option Shares, (b) after two (2) years of continuous employment following the Date of Grant, Optionee shall be entitled to exercise the Option as to
sixty-six percent (66%) of the Option Shares and (c) after three (3) years of continuous employment following the Date of Grant, Optionee shall be entitled to exercise the Option as to one-hundred percent (100%) of the Option
Shares. Optionee shall be considered to be employed by the Company for all purposes under this Paragraph 1 if Optionee is an Eligible Person (as that term is defined in the Plan). The Compensation Committee of the Board of Directors of the
Company (the “Committee”) shall have discretion to determine whether Optionee has ceased to be employed by the Company or any Parent or Subsidiary of the Company and the effective date on which such employment terminated (the
“Termination Date”). Notwithstanding anything contained herein to the contrary, if the corporate position of Optionee is at any time altered or revised such that Optionee’s responsibilities are materially reduced or decreased for any
reason, as determined by the Committee in its sole discretion, the vesting of Shares under this Paragraph 1 shall cease, effective as of the date of such reduction in Optionee’s employment responsibilities; provided, however, except as
otherwise provided in this Agreement and the Plan, Employee shall have the right to exercise this Option with respect to Shares which have vested under this Paragraph 1 as of the date of such reduction of Optionee’s responsibilities.

 Notwithstanding the vesting schedule set forth in this Paragraph 1, but subject to the terms and conditions of this Option, this Option
shall immediately become fully exercisable and may be exercised with respect to all of the Options Shares in the event there is a “Change of Control.” The term “Change in Control” means the occurrence of any of the following
events: 
 (a) any person, within the meaning of Section 13(d)(3) of the Securities Exchange Act of 1934, as amended (the “Exchange
Act”), or group of persons, within the meaning of Exchange Act Rule 13d-5, acquires more than fifty (50) percent in voting power of the Company’s equity securities; 
 (b) the Board of Directors of the Company as it is constituted on any day (the “Incumbent Board”) changes so that on the following day (which
day shall be considered the day upon which the Change in Control occurs) individuals who constitute the Incumbent Board cease for any reason other than their deaths to constitute at least a majority of the Board of Directors, provided that any
individual becoming a director subsequent to the Date of Grant whose election or nomination for election was consented to or approved by a majority of the Incumbent Board shall be, for purposes of this Paragraph (b), considered as though such person
were a member of the Incumbent Board; 
 (c) there is a reorganization (other than a mere change in identity, form, or place of organization
of the Company, however effected), merger or consolidation of the Company, or any other transaction, with one or more business entities or persons as a result of which the stock of the Company is exchanged for or converted into cash or property or
securities not issued by the Company, or as a result of which there is a change in ownership of existing equity securities of the Company or the issuance of new equity securities of the Company (or the right or option to acquire such equity
securities) which exceeds fifty percent (50%) in voting power of the equity securities of the Company outstanding upon completion of such transaction; or 
 (d) there is a sale of (or agreement to sell or grant of a right or option to purchase) all or substantially all of the assets of the Company to any person or business entity. 
 The term Change of Control will not include a public offering of the Company’s common stock registered with the U.S. Securities and Exchange
Commission. 
 2. Restriction on Exercise. This Option may not be exercised unless such exercise is in compliance
with the Securities Act of 1933 and all applicable state securities laws, as they are in effect on the date of exercise, and the 

 
requirements of any stock exchange or national market system on which the Company’s Common Stock may be listed at the time of exercise. Optionee
understands that the Company is under no obligation to register, qualify or list the Shares with the Securities and Exchange Commission (“SEC”), any state securities commission or any stock exchange to effect such compliance. 

3. Termination of Option. 
 (a) Termination Generally. If Optionee’s employment with the Company or any Parent or Subsidiary is terminated by the Company for cause (as determined by the Committee in its sole discretion), then Optionee’s
right to exercise any vested portion of this Option will expire on the Termination Date. If Optionee’s employment with the Company or any Parent or Subsidiary is terminated by the Company without cause or voluntarily by Optionee (whether with
or without good reason), then Optionee’s right to exercise any vested portion of this Option will expire thirty (30) days following the Termination Date. In either such case, any unvested portion of the Option shall expire on the
Termination Date. 
 (b) Death or Disability. If Optionee’s employment with the Company or any Parent or Subsidiary
of the Company is terminated because of the death of Optionee or the disability of Optionee within the meaning of Section 422(e)(3) of the Code, this Option, to the extent (and only to the extent) that it would have been exercisable by Optionee
on the date on which Optionee’s employment is terminated as a result of Optionee’s death or disability, may be exercised by Optionee (or, in the event of Optionee’s death, by Optionee’s legal representative) at any time prior to
the Expiration Date. 
 (c) No Right to Employment. Nothing in the Plan or this Grant shall confer on Optionee any right
to continue in the employ of, or other relationship with, the Company or any Parent or Subsidiary of the Company or limit in any way the right of the Company or any Parent or Subsidiary of the Company to terminate Optionee’s employment or other
relationship at any time, with or without cause. 
 4. Manner of Exercise. 
 (a) Exercise Agreement. This Option shall be exercisable by delivery to the Company of an executed written Exercise Agreement in the
form of the Exercise Agreement delivered to Optionee herewith, or in such other form as may be approved or accepted by the Company, which shall set forth Optionee’s election to exercise some or all of this Option, the number of Shares being
purchased, any restrictions imposed on the Shares and such other representations, warranties, covenants and agreements as may be required by the Company to comply with applicable securities laws. 
 (b) Exercise Price. Such notice shall be accompanied by full payment of the Exercise Price for the Shares being purchased.
Payment for the Shares may be made in U.S. dollars in cash (by check) or, where permitted by law and approved by the Committee in its sole discretion: (i) by cancellation of indebtedness of the Company to Optionee; (ii) by surrender of
shares of Common Stock of the Company that have been owned by Optionee for more than six (6) months (and which have been paid for within the meaning of SEC Rule 144 and, if such Shares were purchased from the Company by use of a promissory
note, such note has been fully paid with respect to such Shares), or were obtained by the Optionee in the open public market, having a Fair Market Value equal to the exercise price of the Option; (iii) by instructing the Company to withhold
Shares otherwise issuable pursuant to an exercise of the Option having a Fair Market Value equal to the exercise price of the Option (including the withheld Shares); or (iv) by waiver of compensation due or accrued to Optionee for services
rendered. 
 (c) Withholding Taxes. Prior to the issuance of the Shares upon exercise of this Option, Optionee
must pay or make adequate provision for any applicable federal or state withholding obligations of the Company. Where approved by the Committee in its sole discretion, the Optionee may provide for payment of withholding taxes upon exercise of the
Option by requesting that the Company retain Shares with a Fair Market Value equal to the minimum amount of taxes required to be withheld. In such case, the Company shall issue the net number of Shares to the Optionee by deducting the Shares
retained from the Shares exercised. 

 (d) Issuance of Shares. Provided that such notice and payment are in form and
substance satisfactory to counsel for the Company, the Company shall cause the Shares to be issued in the name of Optionee or Optionee’s legal representative. 
 5. Notice of Disqualifying Disposition of ISO Shares. If the Option granted to Optionee herein is an ISO, and if Optionee sells or otherwise disposes of any of the Shares acquired pursuant
to the ISO on or before the later of (a) the date two years after the Date of Grant, or (b) the date one year after exercise of the ISO with respect to the Shares to be sold or disposed, the Optionee shall immediately notify the Company in
writing of such disposition. Optionee acknowledges and agrees that Optionee may be subject to income tax withholding by the Company on the compensation income recognized by the Optionee from any such early disposition by payment in cash or out of
the current wages or other earnings payable to the Optionee. 
 6. Non-transferability of Option. This Option may not be
transferred in any manner other than by will or by the laws of descent and distribution and may be exercised during the lifetime of the Optionee only by the Optionee. The terms of this Option shall be binding upon the executor, administrators,
successors and assigns of the Optionee. 
 7. Interpretation. Any dispute regarding the interpretation of this Stock
Option Grant shall be submitted by Optionee or the Company to the Committee thereof that administers the Plan, which shall review such dispute at its next regular meeting. The resolution of such a dispute by the Committee shall be final and binding
on the Company and Optionee. 
 8. Entire Agreement. The Plan is incorporated herein by this reference. Optionee
acknowledges and agrees that the granting of this Option constitutes a full accord, satisfaction and release of all obligations or commitments made to Optionee by the Company or any of its officers, directors, shareholders or affiliates with respect
to the issuance of any securities or rights to acquire securities, of the Company or any of its affiliates. This Grant and the Plan constitute the entire agreement of the parties hereto and supersede all prior undertakings and agreements with
respect to the subject matter hereof. 
 9. Acknowledgment. Optionee acknowledges and confirms that the Shares
received upon exercise of the Option will be subject to the conditions and limitations set forth in this Grant and the Plan.Appointment Letter - Simon Fraser

 Exhibit 4.30 
  

			
	

	  	One Churchill Place
 London
 EC14 5RP

 Lawrence Dickinson 
 Company Secretary 
 10 March 2009 
 Dear Simon

 I am writing to you about your appointment as a Director of Barclays PLC and Barclays Bank PLC with effect from 10 March 2009. 
  

	1.	Fees 

 As a Non-Executive Director you will
receive a fee of £70,000 per annum, payable monthly in arrears by direct credit into your nominated bank account. In the event that you hold office for part of the year the fees shall be pro-rated accordingly on the basis of one twelfth for
each complete or part month served. £20,000 of this fee, after tax and national insurance, will be used to purchase Barclays PLC shares twice per year, in February and August. These shares will be held on your behalf until you leave the Board.
Enclosed with this letter is an agreement setting out details in respect of this remuneration in Barclays PLC shares, which you are asked to sign and return. 
 Any reasonable out of pocket expenses that you incur in performing your duties as a Director (travelling expenses in attending Board meetings etc.) will be reimbursed in accordance with our standard expenses policy.
The Board (with the Non-Executive Directors abstaining) reviews the level of fees paid to Non-Executive Directors annually. 
  

	2.	Terms of Your Appointment 

 The Directors,
rather than the shareholders in general meeting, have appointed you to the Boards of Barclays PLC and Barclays Bank PLC. As a consequence, you are required to seek re-election at the Barclays PLC Annual General Meeting in 2009. As with all of the
Directors, you will then normally be required to seek re-election at least every three years. 
 Your initial term of office will be for up to
six years. On or before the sixth anniversary of your appointment we will agree with you whether it is appropriate for you to continue for up to another three years. In addition, you will also have an annual review with the Chairman of your
performance as a Non-Executive Director. The Board has also adopted a formal system of self-evaluation, which is carried out on an annual basis. 

 Your appointment as a Non-Executive Director may be terminated by us on six months notice (or immediately
on payment of six months fees in lieu of notice) but would automatically terminate without any entitlement to notice or payment if the Barclays PLC shareholders do not re-elect you whenever you stand for re-election and/or if you are removed from
office by the shareholders. The Board shall also reserve the right to reconsider your appointment as a Director and therefore to terminate your appointment forthwith should there be any material change to your personal circumstances that the Board
believes may affect your appointment as a Director of Barclays PLC and Barclays Bank PLC. A material change shall include, but not be limited to, the following: 
  

	 	•	 	 where you resign, retire or are removed from office from any of your other external appointments (including, but not limited to, any other directorships).

  

	 	•	 	 where you are appointed to any other company, corporate body or other entity (internal or external), which has not been agreed in advance with the Chairman.

  

	 	•	 	 where an incident occurs, which the Board considers could adversely affect the reputation of the Group. 

 Where such a material change occurs, you must inform the Chairman as soon as possible. 
 Should you wish to resign your appointment, you are required to give us not less than six months’ notice. 
  

	3.	Role 

 Attached to this letter is a role
profile for Non-Executive Directors, which has been agreed by the Board. The Board may change this role profile from time to time and the role profile as amended shall, once notified to you, be deemed to form part of this letter in place of the
document attached. 
  

	4.	Time Commitment 

 The Board normally meets
formally 8-10 times a year, including a 11⁄2 day strategy session in November, and will otherwise meet on an ad-hoc basis as required. Directors are also expected to attend the Barclays AGM, which is usually held at the end of April each year,
and be available afterwards to meet with and answer the questions of shareholders. 
 Directors are expected to attend each meeting of the
Board, including those called on an ad-hoc basis to discuss urgent matters, and to set aside sufficient time to consider the papers in respect of those meetings, which are normally sent to Directors in the week prior to the meeting. On average, we
would expect Board matters to take approximately 20-25 working days of your time per annum, not including any membership of Board Committees. 
  

	5.	Committees 

 The Chairman may invite you in
due course to serve as a member of one or more of the principal Board Committees. Additional fees will be paid for membership of Committees, which will be discussed with you at the time, together with the time commitment involved. Any letter of
appointment to a Board Committee will form an addendum to this letter. 
  

 - 2 - 

	6.	Directors Share Qualification 

 Under our
Articles of Association, you will be required to hold £500 in nominal value (2,000 ordinary shares of 25p each) of Barclays shares within two months of your appointment (on or before 10 May 2009). If you would like any assistance in buying
these shares please speak to me. 
 If you already hold Barclays shares, please let me know as soon as possible so that we can make the
necessary announcement under the UKLA’s Disclosure and Transparency Rules. 
  

	7.	Induction and support 

 As part of the
induction of Directors we encourage you to meet some of the key members of our senior management and we will agree a suitable induction programme with you shortly. Ongoing training and briefings on particular topics will be made available at your
request. The services of the Company Secretary and the Barclays Corporate Secretariat are available to assist you with both day-to-day and specific matters in your role as a Director of Barclays. Also, should you feel that there maybe implications
for you personally in carrying out the duties of your directorship, you may seek independent advice on any matter, at the Group’s expense. 
  

	8.	Indemnity 

 For the avoidance of doubt, the
Boards have confirmed that as a Director of Barclays PLC and Barclays Bank PLC you have the benefit of and are able to rely upon the indemnity contained in Article 160 of the Barclays PLC Articles of Association and the identical wording in Article
157 of the Barclays Bank PLC Articles of Association, the terms of which are hereby expressly incorporated into this letter of appointment. Copies of the relevant Articles are attached for your ease of reference. 
 In outline, the effect of the Articles (as restricted by relevant statutory provisions) is to provide an indemnity in respect of certain liabilities
incurred by you in the execution of your duties, provided that the liability does not arise by virtue of your negligence, default, breach of duty or breach of trust in relation to the Bank. A copy of the indemnity wording is attached to this letter.
The indemnity is of course in addition to any other protection available to you by virtue of provisions of statute, common law or indeed any specific contract. 
 I should be grateful if you would confirm receipt of this letter, and your acceptance of the conditional appointments as set out, by signing and returning the enclosed copy. I am available at any time to provide any information you may
need. 
 Yours sincerely 
  

	
	 /s/ Lawrence Dickinson

	Lawrence Dickinson
	Company Secretary

  

 - 3 - 

 I agree to the terms and conditions of my appointment as set out in this letter. 
  

			
	Signed:	 	 /s/ Simon Fraser

		 	Simon Fraser

 Date: March 17, 2009 
  

 - 4 -

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00156-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00156-of-00352.parquet"}]]